Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (27)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  4. Molecular surveillance in the nirsevimab era: lessons from respiratory syncytial virus breakthrough infections

    The Lancet Infectious Diseases

  5. New Vaccines for Chronic Respiratory Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 565-575

  6. Nomophobia and Alcohol, Tobacco, and Cannabis Consumption in Adolescents in Galicia

    Cyberpsychology, Behavior, and Social Networking, Vol. 27, Núm. 4, pp. 261-267

  7. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  8. Primary Care Referral Delays in Oral Cancer Diagnosis: A Meta-Analysis

    Oral Diseases

  9. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

  10. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology, Vol. 32, Núm. 6, pp. 3697-3705